4.8 Article

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 382, Issue 17, Pages 1653-1659

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMsr2005760

Keywords

-

Ask authors/readers for more resources

The effects of renin-angiotensin-aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hypothesize that ACE2 may be beneficial rather than harmful during lung injury and suggest that RAAS-inhibitor withdrawal may be harmful in some high-risk patients with known or suspected Covid-19.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available